CD103+ cDCs has been rarely detected and their abundance within tumor tissues is associated with good prognosis and their expansion and activation at tumor sites enhances tumor responses to PD-1 blockade and targeted therapy [33, 35, 36]. Here, ITGAE is linked to neoplasm.